SA518400037B1 - -n،n تــركــيــبـة أكـريـلات ثـنـائـي مـيـثـيـل أمـيـن الإيـثـيـل مـثـبـتـة فـيـمـا يـتـعـلـق بـآثـار تـغـيـر الـلـون - Google Patents

-n،n تــركــيــبـة أكـريـلات ثـنـائـي مـيـثـيـل أمـيـن الإيـثـيـل مـثـبـتـة فـيـمـا يـتـعـلـق بـآثـار تـغـيـر الـلـون

Info

Publication number
SA518400037B1
SA518400037B1 SA518400037A SA518400037A SA518400037B1 SA 518400037 B1 SA518400037 B1 SA 518400037B1 SA 518400037 A SA518400037 A SA 518400037A SA 518400037 A SA518400037 A SA 518400037A SA 518400037 B1 SA518400037 B1 SA 518400037B1
Authority
SA
Saudi Arabia
Prior art keywords
dimethylaminoethyl acrylate
respect
acrylate composition
composition stabilized
discoloring effects
Prior art date
Application number
SA518400037A
Other languages
English (en)
Inventor
فاني دوبوت
بينوات ريفلاد
ساندرا ماغيت
Original Assignee
اركيمـا فرانس
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اركيمـا فرانس filed Critical اركيمـا فرانس
Publication of SA518400037B1 publication Critical patent/SA518400037B1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
    • B01D3/10—Vacuum distillation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
    • B01D3/14—Fractional distillation or use of a fractionation or rectification column
    • B01D3/143—Fractional distillation or use of a fractionation or rectification column by two or more of a fractionation, separation or rectification step
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
    • D21H17/20—Macromolecular organic compounds
    • D21H17/33—Synthetic macromolecular compounds
    • D21H17/34—Synthetic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D21H17/41—Synthetic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds containing ionic groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/08—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to an acyclic carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/07—Aldehydes; Ketones
    • C08K5/08—Quinones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/17—Amines; Quaternary ammonium compounds
    • C08K5/175—Amines; Quaternary ammonium compounds containing COOH-groups; Esters or salts thereof

Abstract

يتعلق الاختراع الحالي باستخدام تركيبة 2،6-ثنائي-ثلاثي-بيوتيل-4-فينول الميثيل 2,6-di-tert-butyl-4-methylphenol بشق يتراوح من 25 إلى 200 جزء لكل مليون جزء لأجل جعل تركيبة N،N-أكريلات ثنائي ميثيل أمين إيثيل N,N-dimethylaminoethyl acrylate ثابتة ضد تأثيرات التلون. كما يتعلق الاختراع كذلك بالحصول على N،N-أكريلات ثنائي ميثيل أمين إيثيل N,N-dimethylaminoethyl acrylate ثابتة بالطريقة المذكورة وبطريقة لأنتاج التركيبة المذكورة
SA518400037A 2016-04-28 2018-09-17 -n،n تــركــيــبـة أكـريـلات ثـنـائـي مـيـثـيـل أمـيـن الإيـثـيـل مـثـبـتـة فـيـمـا يـتـعـلـق بـآثـار تـغـيـر الـلـون SA518400037B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1653798A FR3050731B1 (fr) 2016-04-28 2016-04-28 Composition d'acrylate de n,n-dimethyl aminoethyle stabilisee vis-a-vis de la coloration

Publications (1)

Publication Number Publication Date
SA518400037B1 true SA518400037B1 (ar) 2021-06-16

Family

ID=56263938

Family Applications (1)

Application Number Title Priority Date Filing Date
SA518400037A SA518400037B1 (ar) 2016-04-28 2018-09-17 -n،n تــركــيــبـة أكـريـلات ثـنـائـي مـيـثـيـل أمـيـن الإيـثـيـل مـثـبـتـة فـيـمـا يـتـعـلـق بـآثـار تـغـيـر الـلـون

Country Status (9)

Country Link
US (1) US10479757B2 (ar)
EP (1) EP3448834B1 (ar)
JP (1) JP6918833B2 (ar)
KR (1) KR102362635B1 (ar)
CN (1) CN109071416B (ar)
BR (1) BR112018069067B1 (ar)
FR (1) FR3050731B1 (ar)
SA (1) SA518400037B1 (ar)
WO (1) WO2017187067A1 (ar)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11767381B2 (en) 2021-09-29 2023-09-26 Snf Group 2-dimethylaminoethyl acrylate polymers and their preparation method
CN115873171A (zh) * 2021-09-29 2023-03-31 爱森（中国）絮凝剂有限公司 丙烯酸2-二甲氨基乙酯聚合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3085914B2 (ja) 1996-12-27 2000-09-11 株式会社日本触媒 色安定化された塩基モノマー類の調製方法
FR2777561B1 (fr) 1998-04-21 2000-06-02 Atochem Elf Sa Procede de fabrication en continu de (meth)acrylates de dialkylaminoalkyle
JP4375844B2 (ja) * 1998-08-24 2009-12-02 株式会社日本触媒 アルキルアミノ（メタ）アクリレートの取扱い方法および貯蔵装置
FR2811986B1 (fr) 2000-07-18 2004-02-27 Atofina Procede de fabrication en continu de (meth)acrylates de dialkylaminoalkyle
DE10127939A1 (de) * 2001-06-08 2002-05-29 Basf Ag Verfahren zur Herstellung von (Meth)acrylsäureestern
DE10127938A1 (de) 2001-06-08 2002-07-25 Basf Ag Verfahren zur Herstellung von (Meth)acrylsäureestern
FR2941452B1 (fr) 2009-01-27 2011-02-11 Arkema France Procede de purification de la fraction azeotropique generee lors de la synthese de l'acrylate de n,n-dimethyl aminoethyle
FR2980476B1 (fr) 2011-09-27 2013-08-30 Arkema France Procede de valorisation de produits nobles dans un procede de production de (meth)acrylates de dialkylaminoalkyle

Also Published As

Publication number Publication date
BR112018069067B1 (pt) 2022-04-05
BR112018069067A2 (pt) 2019-01-29
KR102362635B1 (ko) 2022-02-11
EP3448834B1 (fr) 2023-03-15
WO2017187067A1 (fr) 2017-11-02
CN109071416A (zh) 2018-12-21
US20190135731A1 (en) 2019-05-09
FR3050731B1 (fr) 2018-04-20
JP6918833B2 (ja) 2021-08-11
EP3448834A1 (fr) 2019-03-06
FR3050731A1 (fr) 2017-11-03
KR20190003543A (ko) 2019-01-09
CN109071416B (zh) 2021-05-11
US10479757B2 (en) 2019-11-19
JP2019514920A (ja) 2019-06-06

Similar Documents

Publication Publication Date Title
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
MX2019007021A (es) Anticuerpos il-11ra.
MY192848A (en) Compositions and methods for the treatment of hemoglobinopathies
MX2019007020A (es) Anticuerpos il-11.
PH12017502180A1 (en) Tau-binding antibodies
MX2020006595A (es) Oxadiazoles fungicidas.
MX2018013038A (es) Anticuerpos anti-il-33, composiciones, metodos y usos de los mismos.
MY186334A (en) Anti-her2 antibodies and immunoconjugates
PH12016502142A1 (en) Anti-ptk7 antibody-drug conjugates
MX2022000053A (es) Moduladores de interaccion de sestrina-gator2 y sus usos.
MX2017016169A (es) Anticuerpos anti-her2 y metodos de uso.
PH12017502207A1 (en) Tau-binding antibodies
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2020010657A (es) Derivados de oxadiazolina.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2016012053A (es) Procedimiento de compuesto antifungico.
MX2016012056A (es) Procedimiento de compuesto antifungico.
MX2018000395A (es) Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
SG11201901752RA (en) Method for improving aftertaste of alcoholic beverages using allulose
MX2018012797A (es) Inhibidores de erbb y usos de los mismos.
SA518400037B1 (ar) -n،n تــركــيــبـة أكـريـلات ثـنـائـي مـيـثـيـل أمـيـن الإيـثـيـل مـثـبـتـة فـيـمـا يـتـعـلـق بـآثـار تـغـيـر الـلـون
PH12019502694A1 (en) Anti-trkb antibodies
MX2019013700A (es) Composiciones y metodos para el tratamiento de complicaciones y trastornos que se relacionan con el factor de von willebrand.
MX2019012882A (es) Cepa de microbacterium y metodo para producir psicosa utilizando la misma.
PH12017501601A1 (en) Use of isolated fractions of mastic gum for treating optic neuropathy